[1]刘 彻,艾力·赛丁,苏鹏程.甲状腺乳头状癌颈部淋巴结转移特点及相关危险因素分析[J].医学信息,2019,32(23):70-72,77.[doi:10.3969/j.issn.1006-1959.2019.23.019]
　LIU Che,Aili·SaiDing,SU Peng-cheng.Analysis of Cervical Lymph Node Metastasis and Related Risk Factors in Papillary Thyroid Carcinoma[J].Medical Information,2019,32(23):70-72,77.[doi:10.3969/j.issn.1006-1959.2019.23.019]
点击复制

甲状腺乳头状癌颈部淋巴结转移特点及相关危险因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年23期
页码:
70-72,77
栏目:
论著
出版日期:
2019-12-01

文章信息/Info

Title:
Analysis of Cervical Lymph Node Metastasis and Related Risk Factors in Papillary Thyroid Carcinoma
文章编号:
1006-1959（2019）23-0070-04
作者:
刘 彻1; 艾力·赛丁2; 苏鹏程2
（1.石河子大学医学院，新疆 石河子 832000；2.新疆维吾尔自治区人民医院乳腺甲状腺科，新疆 乌鲁木齐 830000）
Author(s):
LIU Che1; Aili·SaiDing2; SU Peng-cheng2
(1.Shihezi University Medical College,Shihezi 832000 Xinjiang,China;2.Department of Breast and Thyroid,People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000,Xinjiang,China)
关键词:
甲状腺乳头状癌; 中央组; 侧区; 淋巴结转移
Keywords:
Papillary thyroid carcinoma; Central group; Lateral area; Lymph node metastasis
分类号:
R736.1
DOI:
10.3969/j.issn.1006-1959.2019.23.019
文献标志码:
A
摘要:
目的 探讨甲状腺乳头状癌（PTC）临床病理特征及影响颈部淋巴结转移的危险因素。方法 回顾性分析我院2015年1月~2017年12月收治的515例PTC的临床资料，分析颈部淋巴结转移特点及相关危险因素。结果 PTC颈部淋巴结转移率为44.27%，中央组（Ⅵ区）淋巴结转移率高于侧区（P＜0.05）。单因素分析结果示性别、年龄、多灶、癌灶最大径、侵犯被膜和颈部淋巴结转移有关（P＜0.05）。多因素分析结果示男性、年龄＜55岁、多灶病变、癌灶最大径＞10 mm、被膜受侵犯是发生颈部淋巴结转移的独立危险因素（P＜0.05）。结论 Ⅵ区转移率最高，行颈淋巴结清扫时应将Ⅵ区作为常规清扫区域。对于男性、年轻、多灶病变、癌灶最大径＞10 mm、被膜受侵犯的患者应高度警惕颈部淋巴结转移的可能。
Abstract:
Objective To investigate the clinicopathological features of papillary thyroid carcinoma (PTC) and the risk factors affecting cervical lymph node metastasis. Methods The clinical data of 515 patients with PTC admitted to our hospital from January 2015 to December 2017 were retrospectively analyzed. The characteristics of cervical lymph node metastasis and related risk factors were analyzed. Results The lymph node metastasis rate of PTC was 44.27%. The lymph node metastasis rate of the central group (VI area) was higher than that of the lateral area (P<0.05). Univariate analysis showed gender, age, multifocal, maximum tumor diameter, invasion of the capsule and cervical lymph node metastasis (P<0.05). Multivariate analysis showed that males, age <55 years, multifocal lesions, maximum tumor diameter >10 mm, and capsule involvement were independent risk factors for cervical lymph node metastasis (P<0.05). Conclusion The metastasis rate of the VI area is the highest. The VI area should be used as the routine cleaning area when the neck lymph node is cleaned. For male, young, multifocal lesions, patients with a maximum diameter of >10 mm, and the capsule is invaded, patients should be highly alert to the possibility of cervical lymph node metastasis.

参考文献/References:

[1]Lim H,Devesa SS,Sosa JA,et al.Trends in thyroid cancer incidence and mortality in the United States 1974-2013[J].JAMA,2017,317(13):1338-1348.[2]Mc Leod DS,Sawka AM,Cooper DS.Controversies in primary treatment of low-risk papillary thyroid cancer[J].Lancet,2013,381(9871):1046-1057.[3]Dimov RS.The effect of neck dissection on quality of life inpatients with differentiated thyroid cancer[J].Gland Surg,2013,2(4):219-226.[4]Cooper DS,Doherty GM,Haugen BR,et al.Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2009(19):1167-1214. [5]Takada H,Kikumort T,Imai T,et al.Patterns of lymph node metastases in papillary thyroid carcinoma:results from consecutive bilateral cervical lymph node dissection[J].World J Surg,2011,35(7):1560-1566. [6]Nguyen MT,Hu J,Hastings KG,et al.Thyroid cancer mortality is higher in Filipinos in the United States:An analysis using National Mortality Records from 2003 through 2012[J].Cancer,2017,123(24):4860-4867. [7]Lan X,Sun W,Zhang H,et al.A meta-analysis of central lymph node metastasis for redicting lateral involvement in papillary thyroid carcinoma[J].Otolaryngol Head Neck Surg,2015,153(5):731-738.

相似文献/References:

[1]郑时玉,郭亚男.c-Met及MACC1在甲状腺乳头状癌中的表达及临床意义[J].医学信息,2022,35(15):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
　ZHENG Shi-yu,GUO Ya-nan.Expression and Clinical Significance of c-Met and MACC1 in Papillary Thyroid Carcinoma[J].Medical Information,2022,35(23):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
[2]李 想,孙春雷,张 懿,等.无充气腋窝入路腔镜手术治疗甲状腺乳头状癌的疗效研究[J].医学信息,2021,34(04):115.[doi:10.3969/j.issn.1006-1959.2021.04.030]
　LI Xiang,SUN Chun-lei,ZHANG Yi,et al.Study on the Curative Effect of Laparoscopic Surgery Non-inflated Axillary Approach in the Treatment of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(23):115.[doi:10.3969/j.issn.1006-1959.2021.04.030]
[3]唐嘉晨,郝玲玲,秦晓茹,等.全腔镜下甲状腺乳头状癌并发症Meta分析[J].医学信息,2021,34(04):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
　TANG Jia-chen,HAO Ling-ling,QIN Xiao-ru,et al.Meta-analysis of Complications of Papillary Thyroid Carcinoma Under Full Laparoscopic Surgery[J].Medical Information,2021,34(23):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
[4]范雪峰,王伦锋,余招焱,等.左侧及右侧中央区淋巴结清扫在甲状腺乳头状癌术中的应用[J].医学信息,2021,34(09):5.[doi:10.3969/j.issn.1006-1959.2021.09.002]
　FAN Xue-feng,WANG Lun-feng,YU Zhao-yan,et al.Left and Right Central Lymph Node Dissection in the Operation of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(23):5.[doi:10.3969/j.issn.1006-1959.2021.09.002]
[5]徐海燕,潘景润,宫希军,等.CT增强联合甲状腺球蛋白及抗体在甲状腺乳头状癌颈部淋巴结转移中的预测价值[J].医学信息,2021,34(20):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
　XU Hai-yan,PAN Jing-run,GONG Xi-jun,et al.The Value of CT Enhancement Combined with Thyroglobulin and Antibody in PredictingCervical Lymph Node Metastasis of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(23):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
[6]李佳楠,陈春悠.STAT3、NCK1和VEGF在甲状腺乳头状癌中的表达及临床意义[J].医学信息,2022,35(05):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
　LI Jia-nan,CHEN Chun-you.Expression of STAT3, NCK1 and VEGF in Papillary Thyroid Carcinoma and its Clinical Significance[J].Medical Information,2022,35(23):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
[7]李雪松,苏新良,陶冬梅.术前诊断不明确的甲状腺乳头状癌的风险分析[J].医学信息,2024,37(04):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]
　LI Xue-song,SU Xin-liang,TAO Dong-mei.Risk Analysis of Papillary Thyroid Carcinoma with Undefinable Preoperative Diagnosis[J].Medical Information,2024,37(23):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]

更新日期/Last Update: 2019-12-01